What is the recommended dose of Cefaclor (Cephalosporin antibiotic) for pediatric patients with varying ages and weights, considering potential allergies to penicillin or other cephalosporins?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefaclor Dosing for Pediatric Patients

The recommended dose of cefaclor in children is 20 mg/kg/day divided every 8 hours for most infections, with 40 mg/kg/day (maximum 1 g/day) reserved for more serious infections, otitis media, or infections caused by less susceptible organisms. 1

Standard Dosing Algorithm

For Mild to Moderate Infections

  • Administer 20 mg/kg/day divided into three doses every 8 hours 1
  • This dosing applies to uncomplicated respiratory tract infections, skin and soft tissue infections, and urinary tract infections 1

For More Serious Infections

  • Increase to 40 mg/kg/day divided every 8 hours, with a maximum daily dose of 1 gram 1
  • This higher dose is specifically indicated for:
    • Otitis media 1, 2
    • Pneumonia 1
    • Infections caused by less susceptible organisms 1

Alternative Twice-Daily Dosing Option

For otitis media and pharyngitis only, cefaclor may be administered every 12 hours instead of every 8 hours 1:

  • Pharyngitis: 20 mg/kg/day divided twice daily 1
  • Otitis media: 40 mg/kg/day divided twice daily 1

Practical Weight-Based Examples

Standard Dose (20 mg/kg/day):

  • 9 kg child: 1/2 teaspoon (125 mg/5 mL suspension) three times daily 1
  • 18 kg child: 1 teaspoon (125 mg/5 mL suspension) three times daily OR 1/2 teaspoon (250 mg/5 mL suspension) three times daily 1

High Dose (40 mg/kg/day):

  • 9 kg child: 1 teaspoon (125 mg/5 mL suspension) three times daily OR 1/2 teaspoon (250 mg/5 mL suspension) three times daily 1
  • 18 kg child: 1 teaspoon (250 mg/5 mL suspension) three times daily 1

Treatment Duration

  • Streptococcal infections: Minimum 10 days of therapy is required to prevent rheumatic fever 1
  • Other infections: Typically 5-10 days depending on clinical response 3

Important Clinical Considerations

Penicillin/Cephalosporin Allergy

  • Cefaclor is contraindicated in patients with known cephalosporin allergy 1
  • For patients with penicillin allergy, exercise caution as cross-reactivity occurs in approximately 10% of cases 1
  • If the patient has a history of immediate hypersensitivity to penicillin (anaphylaxis, urticaria), avoid cefaclor and use alternative agents such as macrolides or clindamycin 4

Spectrum of Activity

  • Cefaclor demonstrates excellent activity against beta-lactamase-producing Haemophilus influenzae resistant to ampicillin, making it particularly useful for otitis media 5, 3
  • Effective against Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus 5, 3

Administration Considerations

  • Food delays absorption but does not significantly reduce bioavailability 5
  • Peak serum levels of approximately 8 mcg/mL occur at 1 hour after a 10 mg/kg dose 3
  • Rapid elimination with virtually undetectable levels at 4 hours, necessitating three-times-daily dosing for most infections 3

Common Pitfalls to Avoid

  • Underdosing otitis media: The standard 20 mg/kg/day dose may be insufficient for otitis media; use 40 mg/kg/day 5, 2
  • Inadequate duration for streptococcal pharyngitis: Always complete a full 10-day course to prevent complications 1
  • Using once-daily dosing for serious infections: The short half-life of cefaclor requires three-times-daily administration for optimal efficacy 3

Renal Impairment

  • Dosage adjustment is typically not required in pediatric patients with renal impairment, though monitoring is recommended 1

References

Guideline

Clindamycin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of cefaclor.

American journal of hospital pharmacy, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.